|
ASX - By Stock
|
AI1 |
Re:
Taken a position
|
|
Mom88
|
21 |
8.0K |
1 |
21/11/25 |
| 21/11/25 |
ASX - By Stock
|
21
|
8.0K
|
1
|
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Trial Promising Improvements in Functional Outcomes
|
|
Mom88
|
58 |
8.2K |
4 |
16/10/25 |
| 16/10/25 |
ASX - By Stock
|
58
|
8.2K
|
4
|
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Phase 2 Trial Promising Improvements in Functional Outcomes
|
|
Mom88
|
58 |
8.2K |
3 |
15/10/25 |
| 15/10/25 |
ASX - By Stock
|
58
|
8.2K
|
3
|
|
|
ASX - By Stock
|
HMI |
Re:
Ann: Appendix 4E and Preliminary Final Report
|
|
Mom88
|
6 |
1.2K |
0 |
05/10/25 |
| 05/10/25 |
ASX - By Stock
|
6
|
1.2K
|
0
|
|
|
ASX - By Stock
|
HMI |
Re:
Ann: Appendix 4E and Preliminary Final Report
|
|
Mom88
|
6 |
1.2K |
0 |
04/10/25 |
| 04/10/25 |
ASX - By Stock
|
6
|
1.2K
|
0
|
|
|
ASX - By Stock
|
EV8 Mining |
Re:
Floats tomorrow
|
|
Mom88
|
15 |
4.2K |
2 |
23/09/25 |
| 23/09/25 |
ASX - By Stock
|
15
|
4.2K
|
2
|
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Topline Phase 2 Trial Results of ARG-007 in AIS Patients
|
|
Mom88
|
165 |
40K |
4 |
09/09/25 |
| 09/09/25 |
ASX - By Stock
|
165
|
40K
|
4
|
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Topline Phase 2 Trial Results of ARG-007 in AIS Patients
|
|
Mom88
|
165 |
40K |
5 |
09/09/25 |
| 09/09/25 |
ASX - By Stock
|
165
|
40K
|
5
|
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Topline Phase 2 Trial Results of ARG-007 in AIS Patients
|
|
Mom88
|
165 |
40K |
7 |
09/09/25 |
| 09/09/25 |
ASX - By Stock
|
165
|
40K
|
7
|
|
|
ASX - By Stock
|
AB1 |
Re:
AB1 Share Price update
|
|
Mom88
|
849 |
436K |
3 |
25/05/25 |
| 25/05/25 |
ASX - By Stock
|
849
|
436K
|
3
|
|
|
ASX - By Stock
|
AI1 |
Re:
Ann: Initial Director's Interest Notice
|
|
Mom88
|
35 |
18K |
3 |
06/03/25 |
| 06/03/25 |
ASX - By Stock
|
35
|
18K
|
3
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gallium & Rare-Earth Exploration Advances at Ivigtut
|
|
Mom88
|
13 |
3.7K |
2 |
05/12/24 |
| 05/12/24 |
ASX - By Stock
|
13
|
3.7K
|
2
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gallium & Rare-Earth Exploration Advances at Ivigtut
|
|
Mom88
|
13 |
3.7K |
0 |
05/12/24 |
| 05/12/24 |
ASX - By Stock
|
13
|
3.7K
|
0
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Application for quotation of securities - EPM
|
|
Mom88
|
1 |
971 |
4 |
24/11/24 |
| 24/11/24 |
ASX - By Stock
|
1
|
971
|
4
|
|
|
ASX - By Stock
|
PHL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mom88
|
10 |
4.0K |
1 |
07/11/24 |
| 07/11/24 |
ASX - By Stock
|
10
|
4.0K
|
1
|
|
|
ASX - By Stock
|
MNC |
Re:
Ann: Notice of Initial Substantial Holder
|
|
Mom88
|
18 |
8.2K |
1 |
07/11/24 |
| 07/11/24 |
ASX - By Stock
|
18
|
8.2K
|
1
|
|
|
ASX - By Stock
|
MNC |
Re:
Ann: ASX Market Announcement - Admission and Quotation
|
|
Mom88
|
27 |
16K |
1 |
04/11/24 |
| 04/11/24 |
ASX - By Stock
|
27
|
16K
|
1
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Mom88
|
5 |
1.8K |
0 |
30/10/24 |
| 30/10/24 |
ASX - By Stock
|
5
|
1.8K
|
0
|
|
|
ASX - By Stock
|
ICI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Mom88
|
10 |
5.0K |
3 |
30/10/24 |
| 30/10/24 |
ASX - By Stock
|
10
|
5.0K
|
3
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Unlocking Uranium Potential in the NT
|
|
Mom88
|
15 |
5.9K |
3 |
22/10/24 |
| 22/10/24 |
ASX - By Stock
|
15
|
5.9K
|
3
|
|
|
ASX - By Stock
|
AGN |
Re:
Ann: New Appointments to the Board of Directors
|
|
Mom88
|
31 |
11K |
2 |
21/09/24 |
| 21/09/24 |
ASX - By Stock
|
31
|
11K
|
2
|
|
|
ASX - By Stock
|
AGN |
Re:
Ann: New Appointments to the Board of Directors
|
|
Mom88
|
31 |
11K |
1 |
20/09/24 |
| 20/09/24 |
ASX - By Stock
|
31
|
11K
|
1
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Mom88
|
8 |
3.1K |
0 |
22/08/24 |
| 22/08/24 |
ASX - By Stock
|
8
|
3.1K
|
0
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Historical Drill Core from Ivigtut Project to be Tested
|
|
Mom88
|
37 |
12K |
0 |
18/06/24 |
| 18/06/24 |
ASX - By Stock
|
37
|
12K
|
0
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: A$18.7m Osteopore, NDCS and A*STAR project hits milestones
|
|
Mom88
|
93 |
38K |
1 |
07/06/24 |
| 07/06/24 |
ASX - By Stock
|
93
|
38K
|
1
|
|
|
ASX - By Stock
|
OSX |
Re:
News: OSX Osteopore Raises A$2.9M From Entitlement Offer
|
|
Mom88
|
95 |
39K |
2 |
20/05/24 |
| 20/05/24 |
ASX - By Stock
|
95
|
39K
|
2
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Annual Report to Shareholders
|
|
Mom88
|
14 |
6.5K |
1 |
19/04/24 |
| 19/04/24 |
ASX - By Stock
|
14
|
6.5K
|
1
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Reinstatement to Official Quotation
|
|
Mom88
|
18 |
7.8K |
4 |
19/04/24 |
| 19/04/24 |
ASX - By Stock
|
18
|
7.8K
|
4
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
15 |
7.0K |
1 |
05/04/24 |
| 05/04/24 |
ASX - By Stock
|
15
|
7.0K
|
1
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
15 |
7.0K |
2 |
03/04/24 |
| 03/04/24 |
ASX - By Stock
|
15
|
7.0K
|
2
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
32K |
1 |
29/03/24 |
| 29/03/24 |
ASX - By Stock
|
63
|
32K
|
1
|
|
|
ASX - By Stock
|
BB1 |
Re:
The float
|
|
Mom88
|
91 |
55K |
1 |
29/03/24 |
| 29/03/24 |
ASX - By Stock
|
91
|
55K
|
1
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
32K |
1 |
28/03/24 |
| 28/03/24 |
ASX - By Stock
|
63
|
32K
|
1
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
32K |
3 |
28/03/24 |
| 28/03/24 |
ASX - By Stock
|
63
|
32K
|
3
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Mom88
|
63 |
32K |
6 |
28/03/24 |
| 28/03/24 |
ASX - By Stock
|
63
|
32K
|
6
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
21K |
2 |
27/03/24 |
| 27/03/24 |
ASX - By Stock
|
45
|
21K
|
2
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
21K |
0 |
18/03/24 |
| 18/03/24 |
ASX - By Stock
|
45
|
21K
|
0
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
21K |
3 |
15/03/24 |
| 15/03/24 |
ASX - By Stock
|
45
|
21K
|
3
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
21K |
5 |
14/03/24 |
| 14/03/24 |
ASX - By Stock
|
45
|
21K
|
5
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
21K |
3 |
14/03/24 |
| 14/03/24 |
ASX - By Stock
|
45
|
21K
|
3
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Mom88
|
45 |
21K |
3 |
13/03/24 |
| 13/03/24 |
ASX - By Stock
|
45
|
21K
|
3
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Investor Presentation
|
|
Mom88
|
4 |
2.7K |
0 |
07/03/24 |
| 07/03/24 |
ASX - By Stock
|
4
|
2.7K
|
0
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
17K |
0 |
03/03/24 |
| 03/03/24 |
ASX - By Stock
|
48
|
17K
|
0
|
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Appendix 4E Preliminary Final Report
|
|
Mom88
|
2 |
1.3K |
0 |
01/03/24 |
| 01/03/24 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
|
ASX - By Stock
|
OSX |
Re:
News: OSX Osteopore Says Shareholders Approved Consolidation Of Capital
|
|
Mom88
|
7 |
2.9K |
1 |
23/02/24 |
| 23/02/24 |
ASX - By Stock
|
7
|
2.9K
|
1
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
17K |
1 |
13/02/24 |
| 13/02/24 |
ASX - By Stock
|
48
|
17K
|
1
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
17K |
3 |
13/02/24 |
| 13/02/24 |
ASX - By Stock
|
48
|
17K
|
3
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
17K |
0 |
12/02/24 |
| 12/02/24 |
ASX - By Stock
|
48
|
17K
|
0
|
|
|
ASX - By Stock
|
EPM |
Re:
Ann: Gronnedal REE Project Maiden Inferred Resource Declared
|
|
Mom88
|
48 |
17K |
0 |
09/02/24 |
| 09/02/24 |
ASX - By Stock
|
48
|
17K
|
0
|
|
|
ASX - By Stock
|
CHM |
Re:
Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial
|
|
Mom88
|
73 |
31K |
3 |
08/02/24 |
| 08/02/24 |
ASX - By Stock
|
73
|
31K
|
3
|
|